hMidkine Protein
Human Midkine, Recombinant,E. coli
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Storage | -20°C |
---|---|
Precautions | hMidkine Protein is for research use only and not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Midkine is a heparin-binding multifunctional protein that has anti-apoptotic properties and promotes cell migration and neurite process formation.
Midkine is induced by tissue injury, and is believed to participate in tissue repair.1,2
Midkine has various activities related to neurogenesis; it enhances the survival of embryonic neurons, migration of neurons, neurite outgrowth,1 and clustering of acetylcholine receptors at the neuromuscular junction.
Midkine has in vitro neurotrophic activity for dorsal root ganglia and midbrain dopaminergic neurons.3-5
Midkine activities in tissue repair processes include enhanced migration of macrophages, neutrophils, and osteoblasts.6
Midkine promotes fibrinolytic activity of endothelial cells,7 and synthesis of collagens and glycosaminoglycans in fibroblasts.8,9
In the adult, Midkine expression is restricted to certain tissues.2,11 However, protein expression is induced during inflammation, repair, and oncogenesis.2,11 High expression of Midkine is observed in a variety of human carcinomas (gastric, colon, pancreatic, lung, breast, urinary bladder).12 Serum or urinary levels of truncated Midkine mRNA, with a high specificity for tumor tissues may be used as tumor markers.13
References
1 . Kaneda, N.et al.(1996)J. Biochem. (Tokyo) 119,1150.
2 . Muramatsu, T. (2002) J. Biochem. (Tokyo) 132,359.
3 . Asai, T.et al.(1997)Biochem. Biophys. Res. Commun. 236,66.
4 . Muramatsu, T.(1995)Nihon Shinkei Seishin Yakurigaku Zasshi. 15,275.
5 . Haynes, L.et al.(2001)Prog. Brain Res. 132,313.
6 . Hayashi, K.et al.(2001)Glycoconj. J. 18,401.
7 . Choudhuri, R.et al.(1997)Cancer Res. 57,1814.
8 . Kadomatsu, K.(2000)Nippon Rinsho. 58,1337.
9 . Kurosawa, N.et al. (2000)Eur. J. Biochem. 267,344.
10 . Kadomatsu, K.et al.(1990)J. Cell Biol. 110,607.
11 . Kurtz, A.et al.(1995)Crit. Rev. Oncog. 6,151.
12 . Shimada, H.et al.(2003)Cancer Sci. 94,628.
13 . Shimada, H. et al.(2003)Oncol. Rep. 10,411.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.